GlassScriptPhysician profile
Leandre Kennedy
NPI 1962286518
$7,669.42
in general payments reported to CMS, 2019-2025
9 companies · $5,040 in 2025
The $5,040 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $74.36 · 2024: $2,555 · 2025: $5,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,287 · Travel and Lodging: $2,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,287.32 |
| Travel and Lodging | $2,382.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,483.93 | 2023-2025 | Ortholoc 2 Lapifuse, Augment Injectable, Ortholoc 3di |
| Medical Device Business Services, INC. | $902.11 | 2024 | Na |
| Bone Support INC. | $521.39 | 2024-2025 | Ceramentbone Void Filler, Cerament G |
| Kerecis Limited | $508.23 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Treace Medical Concepts, INC. | $440.17 | 2024-2025 | |
| Sanara Medtech INC. | $252.29 | 2025 | Celleraterx |
| Depuy Synthes Sales INC. | $231.52 | 2024-2025 | Hammerlock, Tfn-Advance, Na |
| Organogenesis INC. | $209.78 | 2025 | Puraply Wound Matrix |
| Orthofix Medical, INC. | $120.00 | 2025 | Truelok |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leandre Kennedy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.